The 2012 BIO International Convention is a few short weeks away, and we are looking forward to this opportunity to come together for connections and partnerships that will lead to tomorrow’s breakthroughs.
The Keynote Luncheon panels are always a highlight of the Convention. This year in Boston we decided to focus on core issues facing the global biotech community with keynote speakers and panelists who will provide timely insights on the economic, policy and business environment that biotech companies are navigating in 2012 and beyond.
On Tuesday, June 19, we will present a high-level discussion with two former U.S. Secretaries of the Treasury. The title pretty well sums up this session: State of the Global Economy: A Conversation with Former Secretary of the Treasury Robert Rubin and Henry M. Paulson, Jr. As the moderator of this panel, I look forward to asking Secretaries Rubin and Paulson to share their unique perspectives on global economic challenges, and how these challenges will affect biotechnology innovation and investment. We’re honored to have these two knowledgeable and experienced decision-makers join us.
Prior to that discussion, I will deliver my annual industry address. Along with providing an update on the industry’s policy challenges and successes of the past year, I will share the stories of some of the scientists who have developed the latest breakthrough medicines—and the patients whose lives have been changed by these biotech innovations. It will be a chance to celebrate our successes for the patients we serve.
On Wednesday, our Keynote Session speakers will look ahead. We’ve invited a panel of top executives from pharmaceutical and traditional biotech companies to discuss where biotech will be in the next ten years and how the pharmaceutical industry landscape is changing, in a session titled Biotech and Big Pharma – What’s Next?
We’ll also hear an address from U.S. Senator John Kerry of Massachusetts. Senator Kerry will highlight what he believes are the biggest challenges threatening the life sciences innovation ecosystem. His perspective as the senior Senator from a state that is home to many innovative biotech companies and as a national leader and former presidential candidate will be extremely valuable to our attendees.
I hope you will take advantage of the opportunity to attend these informative Keynote Luncheon sessions. See you in Boston!